首页工具

登录

搜索结果

Search Results for " trka "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T13208	TrkA-IN-1	Trk receptor	Tyrosine Kinase/Adaptors
	TrkA-IN-1 is a potent and selective inhibitor of Tropomyosin-related kinase A (TrkA) (IC50: 99 nM in a cell-based assay) with analgesic activity.
T40294	ITK/TRKA-IN-1
	ITK/TRKA-IN-1 is a chemical compound that functions as a dual inhibitor of IL-2-inducible T-cell kinase (ITK) and tropomyosin receptor kinase A (TRKA). With an IC50 value of 1.0 nM, it effectively inhibits the activity of ITK, while demonstrating a remarkable 96% inhibition of TRKA.
T73307	TrkA-IN-4
	TrkA-IN-4 是一种有效和具有口服活性的 TrkA 变构抑制剂，是TrkA-IN-3 的前药。TrkA-IN-4 显示出有效的抗伤害作用。
T62801	FLT3/TrKA-IN-1
	FLT3/TrKA-IN-1 是一种有效的 FLT3/TrKA 双激酶抑制剂，能够作用于 FLT3 (IC50: 43.8 nM)、FLT3-ITD (IC50: 97.2 nM)、FLT3-TKD (IC50: 92.5 nM) 和 TrKA (IC50: 23.6 nM)。FLT3/TrKA-IN-1 能够将细胞周期阻滞在 G0/G1 期，并诱导细胞凋亡 (apoptosis)，具有抗增殖作用。FLT3/TrKA-IN-1 具有潜力进行急性髓性白血病 (AML) 的研究。
T73306	TrkA-IN-3
	TrkA-IN-3 是一种有效和亚选择性的TrkA 变构抑制剂，IC50值为 22.4 nM。TrkA-IN-3 对TrkA 的选择性超过TrkB 和TrkC8000 倍。TrkA-IN-3 可用于研究疼痛。
T16766	Ro 08-2750
	Ro 08-2750 是一种非肽和可逆的神经生长因子 (NGF) 抑制剂，与 NGF 结合，IC50 约为 1 µM。它是一种选择性 MSI RNA 结合活性抑制剂，IC50 为 2.7 μM。它选择性抑制 NGF 与 p75NTR 的结合，而不是 TRKA。
T12731	RIPK1-IN-7	RIP kinase	Apoptosis; NF-κB
	RIPK1-IN-7 是一种选择性有效的 RIPK1 抑制剂，Kd 值为 4 nM，IC50值为 11 nM。在实验性 B16 黑色素瘤肺转移模型中表现出优异的抗转移活性。
T9123	DS-1205	TAM Receptor	Tyrosine Kinase/Adaptors
	DS-1205b free base 是有效的AXL 激酶选择性抑制剂，IC50为 1.3 nM。它对MER，MET 和TRKA 也有抑制作用，IC50分别为 63、104 和 407 nM。它可以抑制细胞迁移和肿瘤生长。
T6712	Tyrphostin AG 879 AG 879	Apoptosis; EGFR; Trk receptor; HER; PDGFR	Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
	Tyrphostin AG 879 (AG 879) 是一种抑制TrKA 磷酸化的酪氨酸激酶抑制剂，IC50为 10 μM。它还是一种选择性ErbB2酪氨酸激酶抑制剂，IC50为 1 μM，具有抗癌活性。
T4349	Sitravatinib MG516,MGCD516	Discoidin Domain Receptor (DDR); VEGFR; FLT; Trk receptor; TAM Receptor; c-Kit; Ephrin Receptor	Angiogenesis; Tyrosine Kinase/Adaptors
	Sitravatinib (MGCD516) 是一种有口服活性的受体酪氨酸激酶抑制剂。它单独使用即具有有效的抗肿瘤功效，且通过促进抗肿瘤免疫微环境增强了 PD-1 阻断的活性。
T0678	Amitriptyline hydrochloride Amitriptyline HCl,Tryptizol,盐酸阿米替林,Domical,Annoyltin	Trk receptor; Sigma receptor; 5-HT Receptor; Serotonin Transporter; Sodium Channel; Adrenergic Receptor; AChR; Norepinephrine; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience; Tyrosine Kinase/Adaptors
	Amitriptyline hydrochloride (Annoyltin) 是血清素再摄取转运体和去甲肾上腺素再摄取转运体抑制剂，还与多巴胺再摄取转运体结合，其Ki 为 2.58 μM。它也抑制肾上腺素能受体、毒蕈碱受体、组胺受体、5-羟色胺受体。它是TrkA 和TrkA 受体的激动剂，具有强神经营养活性和有抗抑郁作用。
T39266	hTrkA-IN-1
	hTrkA-IN-1 is a potent and orally active inhibitor of TrkA kinase with an IC 50 of 1.3 nM, compound 2.hTrkA-IN-1 can be used for the study of inflammatory disease, such as prostatitis, pelvic, et al.
T63223	hTrkA-IN-2
	hTrkA-IN-2 是选择性的 hTrkA 变构抑制剂(IC50: 3.9 nM)。
T7435	Selitrectinib LOXO-195	Trk receptor	Tyrosine Kinase/Adaptors
	Selitrectinib (LOXO-195) 是二代原肌凝蛋白相关激酶(TRK)抑制剂，能够作用于 TRKA (IC50:0.6 nM) 和 TRKC (IC50<2.5 nM)。
T5635	CH7057288	Trk receptor	Tyrosine Kinase/Adaptors
	CH7057288 是选择性TRK 抑制剂。
T14921	CE-245677	Tie-2; Trk receptor	Tyrosine Kinase/Adaptors
	CE-245677 是可逆的Tie2和TrkA/B 抑制剂，在细胞体系下的IC50值分别为 4.7 和 1 nM。
T14363	AZ-23 AZ 23,AZ23	Trk receptor	Tyrosine Kinase/Adaptors
	AZ-23是一种 ATP-竞争性的，口服具有活性的 Trk 激酶 A/B/C 抑制剂，IC50值分别为2 nM (TrkA)，8 nM (TrkB)，24 nM (FGFR1)，52 nM (Flt3)，55 nM (Ret)，84 nM (MuSk)，99 nM (Lck)。
T6097	GNF-5837 GNF 5837	Trk receptor; PDGFR; c-Kit	Angiogenesis; Tyrosine Kinase/Adaptors
	GNF-5837 是一种选择性的，有效的，口服生物利用的泛TRK 抑制剂，在 Ba/F3 细胞中显示出抗增殖作用 (对Tel-TrkC,Tel-TrkB 和Tel-TrkA 的IC50值分别为 7 nM，9 nM 和 11 nM)。
T9292	ALE-0540 ALE0540	Others; Trk receptor	Others; Tyrosine Kinase/Adaptors
	ALE-0540是一种非肽类杂环分子，可抑制NGF 与p75和TrkA 的结合，以及TrkA 受体介导的信号转导和生物反应。
T6052	GW 441756	Apoptosis; Raf; Trk receptor; CDK	Apoptosis; Cell Cycle/Checkpoint; MAPK; Tyrosine Kinase/Adaptors
	GW 441756 是一种高特异性神经生长因子受体酪氨酸激酶 a 抑制剂，IC50值为 2 nM，可消除 BmK NSPK 诱导神经突生长。
T4257	Belizatinib TSR-011	Trk receptor; ALK	Angiogenesis; Tyrosine Kinase/Adaptors
	Belizatinib (TSR-011) 是可口服的ALK 和 TRKA、TRKB、TRKC 双重抑制剂，对野生型重组 ALK 的IC50值为0.7 nM。
T3678	Entrectinib RXDX-101,恩曲替尼,NMS-E628	Trk receptor; ROS; ALK; Autophagy; ROS Kinase	Angiogenesis; Autophagy; Immunology/Inflammation; Tyrosine Kinase/Adaptors
	Entrectinib (RXDX-101) 是一种可口服的 Trk、ROS1和 ALK 抑制剂，具有抗肿瘤和中枢神经活性，抑制 TrkA、TrkB、TrkC、ROS1 和 ALK 的 IC50值分别为 1、3、5、12 和 7 nM。
T62447	Paltimatrectinib PBI-200,PPI-5278	Trk receptor; Tyrosine Kinases	Tyrosine Kinase/Adaptors
	Paltimatrectinib (PBI-200) 是一种高效的酪氨酸激酶 (tyrosine kinase) 抑制剂，具有抗癌活性，抑制肌球蛋白相关激酶 A (TrkA) 。Paltimatrectinib 可用于研究膀胱癌、乳腺癌和结直肠癌。
T41224	CG 428	Trk receptor	Tyrosine Kinase/Adaptors
	CG 428 是一种有效的原肌球蛋白受体激酶 (TRK) 降解剂 (uSMITETM)，DC50 为 0.36 nM。 CG 428 包含泛 TRK 抑制剂 GNF-8625 的类似物，通过接头连接到 cereblon E3 连接酶配体泊马度胺。 CG 428 对 TRKA 的选择性优于 TRKC 和 TRKB，Kd 为 1nM、4.2 nM 和 28 nM。 CG 428 抑制 KM12 结肠癌细胞的生长，IC50 为 2.9 nM。
T2349	BMS-754807	Trk receptor; c-Met/HGFR; IGF-1R	Tyrosine Kinase/Adaptors
	BMS754807 是一种可逆的IGF-1R 抑制剂 (IC50:1.8 nM，Ki<2 nM)，也是一种可逆的IR 抑制剂 (IC50:7 nM，Ki<2 nM)。它也抑制 Met (IC50:6 nM)，RON (IC50:44 nM)，TrkA (IC50:7 nM)，TrkB (IC50:4 nM)，AurA (IC50:9 nM) 和 AurB (IC50:25 nM) 的活性。
T4071	Repotrectinib TPX-0005,TPX 0005,TPX0005	Trk receptor; ROS; Src; ALK; ROS Kinase	Angiogenesis; Immunology/Inflammation; Tyrosine Kinase/Adaptors
	Repotrectinib (TPX-0005) 是ROS1(IC50=0.07 nM) 和TRK(对 TRKA/B/C 的IC50=0.83/0.05/0.1 nM) 抑制剂，能够抑制 WTALK(IC50=1.01 nM)。它具有抗癌作用。
T5995	Larotrectinib LOXO-101,ARRY-470	Apoptosis; Trk receptor	Apoptosis; Tyrosine Kinase/Adaptors
	Larotrectinib (LOXO-101)为ATP竞争性、口服选择性抑制剂，针对原肌凝蛋白相关激酶(TRK)家族受体三个亚型(TRKA，B 和C)展现纳摩尔级别的50%抑制浓度。
T78968	TRK-IN-23	Trk receptor	Tyrosine Kinase/Adaptors
	TRK-IN-23 (compound 24b) 是一款口服活性TRK抑制剂，对TRKA、TRKC、TRKAG595R、TRKAF589L和TRKAG667C 表现出高效的抑制作用，其IC50值分别为0.5 nM、9 nM、14 nM、4.4 nM和4.8 nM。此外，TRK-IN-23 能够诱导含有TRKAG595R和TRKAG667C突变的Ba/F3细胞系进行细胞凋亡(apoptosis)。
T17169	Trk-IN-4 PF-6683324 isomer	Trk receptor	Tyrosine Kinase/Adaptors
	Trk-IN-4 is an effective pan-Trk inhibitor in cell-based assays (IC50s: 1.9 nM, 2.6 nM, and 1.1 nM for TrkA, TrkB, and TrkC, respectively).
T11729	JTE-952	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuroscience
	JTE-952 is a oral, potent active and selective Type II inhibitor of colony stimulating factor-1 receptor (CSF-1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse
T13207	PF-06733804	Trk receptor	Tyrosine Kinase/Adaptors
	PF-06733804 is a potent inhibitor of pan-Trk in cell-based assays (IC50s: 8.4 nM, 6.2 nM, and 2.2 nM for TrkA, TrkB, and TrkC) with anti-hyperalgesic effect.
T15738	Lestaurtinib KT-5555,CEP-701	Others	Others
	Lestaurtinib is a multi-kinase inhibitor. It also has effective activity against the Trk family of receptor tyrosine kinases. Lestaurtinib inhibits JAK2, FLT3, and TrkA (IC50s: 0.9, 3, and less than 25 nM).
T17000	Tavilermide MIM-D3	Trk receptor	Tyrosine Kinase/Adaptors
	Tavilermide is a selective and partial agonist of TrkA or a nerve growth factor mimetic.
T62672	D5261
	D5261 是一个有效的、类型 III 变构的 tropomyosin-related kinase A (TrkA) 抑制剂。
T29020	TSR-011-isomer TSR011 isomer,TSR-011 isomer,Belizatinib isomer
	TSR011-isomer, a TrKA/ALK inhibitor, is used potentially for the treatment of solid tumours and lymphoma.
T73033	TRK II-IN-1	Trk receptor	Tyrosine Kinase/Adaptors
	TRKII-IN-1 是一种有效的 II 型TRK抑制剂，对TRKA/B/C及TRKAG667C的IC50分别为3.3、6.4、4.3 和 9.4 nM。此外，TRKII-IN-1 对FLT3、RET和VEGFR2也具有抑制作用，其IC50分别为1.3、9.9 和 71.1 nM。TRKII-IN-1 主要用于TRK驱动的癌症研究。
T79706	TRK-IN-24	Trk receptor	Tyrosine Kinase/Adaptors
	TRK-IN-24（compound 10g）是一种针对Trk Receptor的抑制剂，它对TRKA、TRKC、TRKAG595R、TRKAG667C和TRKAF589L的抑制作用的IC50值分别达到5.21、4.51、6.77、1.42和6.13 nM。该化合物在BaF3-CD74-NTRK1G595R和BaF3-CD74-NTRK1G667C异种移植模型中显示出明显的抗肿瘤活性。此外，TRK-IN-24 能有效抑制携带SF、GK、xDFG等单点突变的Ba/F3细胞增殖，其IC50范围为1.43至47.56 nM。
T17170	PF-06737007	Trk receptor	Tyrosine Kinase/Adaptors
	PF-06737007 is an effective inhibitor of pan-Trk in cell-based assays (IC50s: 7.7 nM, 15 nM, and 3.9 nM for TrkA, TrkB, and TrkC, respectively).
T22318	Taletrectinib DS-6051b,AB-106	Trk receptor; ROS; ROS Kinase	Immunology/Inflammation; Tyrosine Kinase/Adaptors
	Taletrectinib (AB-106) 是具有口服活力的、选择性的 ROS1/NTRK 抑制剂。它对重组 ROS1、NTRK1、NTRK2 和 NTRK3 有较强的抑制作用，IC50值分别为 0.207、0.622、2.28 和 0.98 nM。它还抑制 ROS1 G2032R 和其他抗 Crizotinib 的 ROS1 突变体。
T61872	Trk-IN-10
	Trk-IN-10 (Compound 14j) is a highly effective inhibitor of TRK, with an IC50 of 0.86 nM against TrkA and 6.92 nM against TrkA G595R. As an RTK, Trk plays a crucial role as a drug target in solid tumors. Trk-IN-10 (IC50 = 350 nM against ALK) demonstrates superior selectivity in inhibiting Trk, which has potential implications for toxicity reduction [1].
T62341	(R)-Larotrectinib
	(R)-Larotrectinib 是一种 TRK 的有效抑制剂，作用于 TrkA (IC50: 28.5 nM)。(R)-Larotrectinib 能够用于研究癌症、炎症以及某些感染性疾病。
T12925	Sitravatinib malate MGCD516 malate,MG-516 malate	TAM Receptor	Tyrosine Kinase/Adaptors
	Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively.) , shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.
T71121	Milciclib maleate
	Milciclib maleate is an inhibitor of cyclin-dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA).
T62093	Trk-IN-11
	Trk-IN-11 (Compound 14h) 是一种 TRK 的有效抑制剂，对 TrkA、TrkA G595R 的 IC50 值分别为 1.4 nM、1.8 nM。其中原肌球蛋白受体激酶 (Trk) 是一种受体酪氨酸激酶 (RTK)，也是实体瘤中关键的药物靶点。Trk-IN-11对癌症疾病表现出研究潜力。
T62095	TRK-IN-19
	TRK-IN-19 (Compound I-10 ) 是一种 TRK 的有效抑制剂，对 TRKA、TRKAG595R 的 IC50 值分别为 1.1 nM、5.3 nM。TRK-IN-19 对癌症疾病表现出潜在的研究价值。
T39896	ALK-IN-9
	ALK-IN-9 (compound 40) is a highly effective ALK inhibitor. It demonstrates remarkable inhibitory activity against cell proliferation, with IC50 values of <0.2 nM for Ba/F3-EML4-ALK, KM 12 (TPM3-TRKA), and KG-l cell (OP2-FGFR1).
T61443	Trk-IN-7
	Trk-IN-7 (compound I-6) is a highly potent inhibitor of TRK, exhibiting IC50 values ranging from 0.25-10 nM for TRKA, TRKB, and TRKC, respectively. In addition, Trk-IN-7 demonstrates notable inhibition against EML4-ALK (IC50 <15 nM), as well as ALK G1202R, ALK C1156Y, ALK R1275Q, ALK F1174L, ALK L1197M, and ALK G1269A (IC50 = 5-50 nM) [1].
T78221	TRAF6 peptide TFA	E1/E2/E3 Enzyme	Ubiquitination
	TRAF6 peptide TFA是一种抑制TRAF6-p62相互作用的特异性分子，可抑制NGF依赖的TrkA泛素化，展现在阿尔茨海默症（AD）、帕金森病、ALS、创伤性脑损伤、癫痫和中风等神经系统疾病研究中的应用潜力。
T76813	Bedinvetmab
	Bedinvetmab (ZTS-00508841)为针对神经生长因子(NGF)的犬单克隆抗体(mAb)，通过抑制NGF与肌球蛋白原受体激酶A(trkA)及p75神经营养蛋白受体(p75NTR)的相互作用，应用于犬骨关节炎疼痛的研究。
T63076	IHMT-TRK-284
	IHMT-TRK-284 (Compound 34) 是一种有效的、口服具有活力的 type II TRK kinase 抑制剂，能够作用于 TRKA (IC50: 10.5 nM)、TRKB (IC50: 0.7 nM)、TRKC (IC50: 2.6 nM)。IHMT-TRK-284 在激酶组中表现出良好的选择性，体内具有良好的抗肿瘤作用。

化合物

Cat.No: T13208

Target: Trk receptor

ITK/TRKA-IN-1

Cat.No: T40294

Cat.No: T73307

FLT3/TrKA-IN-1

Cat.No: T62801

Cat.No: T73306

Cat.No: T16766

Cat.No: T12731

Target: RIP kinase

Cat.No: T9123

Target: TAM Receptor

Tyrphostin AG 879

Cat.No: T6712

Synonym: AG 879

Target: Apoptosis, EGFR, Trk receptor, HER, PDGFR

Cat.No: T4349

Synonym: MG516,MGCD516

Target: Discoidin Domain Receptor (DDR), VEGFR, FLT, Trk receptor, TAM Receptor, c-Kit, Ephrin Receptor

Amitriptyline hydrochloride

Cat.No: T0678

Synonym: Amitriptyline HCl,Tryptizol,盐酸阿米替林,Domical,Annoyltin

Target: Trk receptor, Sigma receptor, 5-HT Receptor, Serotonin Transporter, Sodium Channel, Adrenergic Receptor, AChR, Norepinephrine, Histamine Receptor

Cat.No: T39266

Cat.No: T63223

Cat.No: T7435

Synonym: LOXO-195

Target: Trk receptor

Cat.No: T5635

Target: Trk receptor

Cat.No: T14921

Target: Tie-2, Trk receptor

Cat.No: T14363

Synonym: AZ 23,AZ23

Target: Trk receptor

Cat.No: T6097

Synonym: GNF 5837

Target: Trk receptor, PDGFR, c-Kit

Cat.No: T9292

Synonym: ALE0540

Target: Others, Trk receptor

Cat.No: T6052

Target: Apoptosis, Raf, Trk receptor, CDK

Cat.No: T4257

Synonym: TSR-011

Target: Trk receptor, ALK

Cat.No: T3678

Synonym: RXDX-101,恩曲替尼,NMS-E628

Target: Trk receptor, ROS, ALK, Autophagy, ROS Kinase

Paltimatrectinib

Cat.No: T62447

Synonym: PBI-200,PPI-5278

Target: Trk receptor, Tyrosine Kinases

Cat.No: T41224

Target: Trk receptor

Cat.No: T2349

Target: Trk receptor, c-Met/HGFR, IGF-1R

Cat.No: T4071

Synonym: TPX-0005,TPX 0005,TPX0005

Target: Trk receptor, ROS, Src, ALK, ROS Kinase

Cat.No: T5995

Synonym: LOXO-101,ARRY-470

Target: Apoptosis, Trk receptor

Cat.No: T78968

Target: Trk receptor

Cat.No: T17169

Synonym: PF-6683324 isomer

Target: Trk receptor

Cat.No: T11729

Target: Histamine Receptor

Cat.No: T13207

Target: Trk receptor

Cat.No: T15738

Synonym: KT-5555,CEP-701

Target: Others

Cat.No: T17000

Synonym: MIM-D3

Target: Trk receptor

Cat.No: T62672

Cat.No: T29020

Synonym: TSR011 isomer,TSR-011 isomer,Belizatinib isomer

Cat.No: T73033

Target: Trk receptor

Cat.No: T79706

Target: Trk receptor

Cat.No: T17170

Target: Trk receptor

Cat.No: T22318

Synonym: DS-6051b,AB-106

Target: Trk receptor, ROS, ROS Kinase

Cat.No: T61872

(R)-Larotrectinib

Cat.No: T62341

Sitravatinib malate

Cat.No: T12925

Synonym: MGCD516 malate,MG-516 malate

Target: TAM Receptor

Milciclib maleate

Cat.No: T71121

Cat.No: T62093

Cat.No: T62095

Cat.No: T39896

Cat.No: T61443

TRAF6 peptide TFA

Cat.No: T78221

Target: E1/E2/E3 Enzyme

Cat.No: T76813

Cat.No: T63076

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼